NCT02613676View on ClinicalTrials.gov

Transcutaneous Screening for Risk of Severe Hyperbilirubinemia in South African Newborns

NACompletedINTERVENTIONAL

Enrollment

1,858

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Neonatal JaundiceHyperbilirubinemia

Interventions

DEVICE

Transcutaneous bilirubin screening

Transcutaneous bilirubin screening before hospital discharge and assessment of risk category according to the Bhutani nomogram

OTHER

Standard care (Visual inspection)

Participants in this group will be assessed for jaundice by visual inspection. Blood draw for TsB will be drawn only if the participant is visibly jaundiced.

Trial Locations (1)

7560

Tygerberg Hospital, Cape Town

All Listed Sponsors

collaborator

Stanford University

OTHER

lead

University of Stellenbosch

OTHER

NCT02613676 - Transcutaneous Screening for Risk of Severe Hyperbilirubinemia in South African Newborns | Biotech Hunter | Biotech Hunter